share_log

ISpecimen Analyst Ratings

Benzinga Analyst Ratings ·  Sep 23, 2022 10:53
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/23/2022 127.27% EF Hutton $5.5 → $4.25 Maintains Buy
01/04/2022 969.52% Craig-Hallum → $20 Initiates Coverage On → Buy
11/22/2021 541.71% EF Hutton $10 → $12 Maintains Buy

iSpecimen Questions & Answers

What is the target price for iSpecimen (ISPC)?

The latest price target for iSpecimen (NASDAQ: ISPC) was reported by Craig-Hallum on January 4, 2022. The analyst firm set a price target for $20.00 expecting ISPC to rise to within 12 months (a possible 969.52% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for iSpecimen (ISPC)?

The latest analyst rating for iSpecimen (NASDAQ: ISPC) was provided by Craig-Hallum, and iSpecimen initiated their buy rating.

When is the next analyst rating going to be posted or updated for iSpecimen (ISPC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iSpecimen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iSpecimen was filed on January 4, 2022 so you should expect the next rating to be made available sometime around January 4, 2023.

Is the Analyst Rating iSpecimen (ISPC) correct?

While ratings are subjective and will change, the latest iSpecimen (ISPC) rating was a initiated with a price target of $0.00 to $20.00. The current price iSpecimen (ISPC) is trading at is $1.87, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment